Skip to main content
OABI
NASDAQ Industrial Applications And Services

OmniAb Reports Exceptional Q1 2026 Revenue Growth and Significantly Reduced Net Loss

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.47
Mkt Cap
$212.83M
52W Low
$1.22
52W High
$2.295
52W Position info
20% above low
Off High info
36% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

OABI sits 20% above its 52-week low of $1.22.

Summary

OmniAb, Inc. reported a 247% year-over-year revenue increase to $14.4 million and a significantly narrowed net loss of $7.7 million for Q1 2026, demonstrating a strong financial turnaround.


Key Events · Earnings and Guidance · OABI

  • Revenue Surges 247% Year-over-Year

    Total revenue for the first quarter of 2026 reached $14.427 million, a substantial increase from $4.154 million in Q1 2025, primarily driven by a $10.0 million increase in license and milestone revenue.

  • Net Loss Significantly Narrows

    The company reported a net loss of $7.707 million in Q1 2026, a significant improvement from a net loss of $18.200 million in Q1 2025.

  • Improved Operating Cash Flow

    Cash used in operating activities decreased to $4.914 million in Q1 2026, compared to $15.872 million in the prior year period, indicating more efficient cash management.

  • Stable Liquidity and 12-Month Runway

    OmniAb maintains $49.1 million in cash, cash equivalents, and short-term investments, which management believes is sufficient to support operations for at least the next 12 months.


Analysis · OABI · Industrial Applications And Services

OmniAb, Inc. delivered a strong first quarter, marked by a substantial increase in revenue and a significant reduction in net loss. The company's revenue soared by 247% year-over-year, driven primarily by license and milestone revenue. This financial improvement, coupled with a reduced cash burn from operations and a stable liquidity position, indicates a positive trajectory for the company. While an impairment charge was recorded, the overall financial performance is overwhelmingly positive, suggesting a potential turnaround.

At the time of this filing, OABI was trading at $1.47 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $212.8M. The 52-week trading range was $1.22 to $2.30. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OABI - Latest Insights

OABI
May 07, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1.47
Real-time Price: $2.01 info
Change: +$0.535 (+36%) info
Market Cap: $288.495M info
OABI
Mar 04, 2026, 4:40 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.75
Real-time Price: $2.01 info
Change: +$0.255 (+15%) info
Market Cap: $288.495M info
OABI
Mar 04, 2026, 4:28 PM EST
Source: Reuters
Importance Score:
8
Price at Filing: $1.75
Real-time Price: $2.01 info
Change: +$0.255 (+15%) info
Market Cap: $288.495M info
OABI
Mar 04, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.75
Real-time Price: $2.01 info
Change: +$0.255 (+15%) info
Market Cap: $288.495M info